Mindray Medical International (MR) Reports In-Line Q1 EPS of 34c
Get Alerts MR Hot Sheet
Join SI Premium – FREE
Mindray Medical International (NYSE: MR) reported Q1 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $219 million versus the consensus estimate of $217.49 million.
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share